Search
for
Sort by
Research 841–870 of 1000+
- Use of oral contraceptives in the management of acne
- Oral Contraceptives: Their Mode of Action and Dermatologic Applications
- Balancing Hormones and Skin Health: A Focus on Oral Contraceptives in Dermatology
- Effects of oral contraceptives on the quality of life of women with polycystic ovary syndrome: a crossover randomized controlled trial
- Effects of oral contraceptives on the quality of life of women with polycystic ovary syndrome: a crossover randomized controlled trial
- Use of oral contraceptives in the management of acne
- Little Evidence Showing Hormonal Contraception Causes Weight Gain
- Oral Contraception and the Treatment of Acne: Where are we?
- 27593 Contraception progestin type and female pattern hair loss
- Combined Oral Contraception and Bicalutamide in Polycystic Ovary Syndrome and Severe Hirsutism: A Double-Blind Randomized Controlled Trial
- Noncontraceptive benefits of the estradiol valerate/dienogest combined oral contraceptive: a review of the literature
- Dienogest vs. combined oral contraceptive: A systematic review and meta‐analysis of efficacy and side effects to inform evidence‐based guidelines
- Changes in the serum metabolomics of polycystic ovary syndrome before and after compound oral contraceptive treatment
- Combined oral contraceptives promote androgen receptor and oestrogen receptor alpha upregulation in the female prostate (Skene’s paraurethral glands) of adult gerbils (Meriones unguiculatus)
- FINASTERIDE (PLUS ORAL CONTRACEPTIVE PILL) VS METFORMIN IN TREATMENT OF POLYCYSTIC OVARY SYNDROME-RELATED INFERTILITY: A PROSPECTIVE RANDOMIZED TRIAL
- Liver function congruence with contraceptive medical profile in women at child-bearing ages
- Use of Finasteride- Oral Contraceptive Pill Combination in the Treatment of Polycystic Ovarian Syndrome Related- Infertility
- Effect of contraceptives on the skin.
- The effect of 2 combined oral Contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea.
- Studies of the components of an oral contraceptive agent in albino rats. I. Estrogenic component
- Problems in evaluating chronic toxicity of contraceptive steroids in dogs
- Studies of the components of an oral contraceptive agent in albino rats. II. Progestogenic component and comparison of effects of the components and the combined agent
- Novel progestogenic androgens for male contraception: design, synthesis, and activity of C7 α-substituted testosterone
- Drug interactions between herbal medicines and oral contraceptives
- Comparison of ovarian electrocautery and oral contraceptives in the treatment of hyperandrogenism in women with polycystic ovary syndrome
- Hormonal manipulation with finasteride or oral contraception does not influence incidence of renal cell carcinoma
- A Case of Alopecia due to Oral Contraceptives
- Inhibition of skin 5α-reductase by oral contraceptive progestins<i>in vitro</i>
- Comparison of Sequential Cyproterone Acetate/Estrogen Versus Spironolactone/Oral Contraceptive in the Treatment of Hirsutism
- Long-term toxicologic and tumorigenesis studies on an oral contraceptive agent in albino rats